Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution

See also
Status	Clinical Trial	Phase
Completed	`NCT03284853` - Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension	Phase 3
Terminated	`NCT03611530` - CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle Glaucoma	N/A
Not yet recruiting	`NCT06441643` - Next Generation Rocklatan	Phase 2
Not yet recruiting	`NCT02868502` - Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma	N/A
Completed	`NCT02628223` - 180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma	N/A
Completed	`NCT02272569` - STARflo European Safety and Efficacy Study	N/A
Completed	`NCT01936389` - A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma	Phase 2
Completed	`NCT00941525` - Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure	Phase 4
Completed	`NCT00539526` - Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues	Phase 4
Completed	`NCT00121147` - Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan	N/A
Active, not recruiting	`NCT05035394` - Swedish Microinvasive Glaucoma Surgery Study (SMIGS)	N/A
Completed	`NCT03450629` - Evaluation of Safety and Efficacy of PDP-716	Phase 3
Active, not recruiting	`NCT06061718` - Travoprost Intraocular Implant in Conjunction With Cataract Surgery	Phase 3
Recruiting	`NCT05241938` - PSLT Compared to Prostaglandin Analogue Eye Drops	N/A
Completed	`NCT01342406` - Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics
Completed	`NCT02250612` - SYL040012, Treatment for Open Angle Glaucoma	Phase 2
Terminated	`NCT01983579` - TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection	Phase 4
Completed	`NCT01937299` - Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®	Phase 4
Completed	`NCT01937312` - Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue	Phase 4
Completed	`NCT01229982` - A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma	Phase 2

NCT number	NCT05938699
Study type	Interventional
Source	Nicox Ophthalmics, Inc.
Contact	Siobhan Garbutt, PhD
Phone	984-710-5354
Email	NCX470@nicox.com
Status	Recruiting
Phase	Phase 2/Phase 3
Start date	December 12, 2023
Completion date	March 31, 2025

Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution — Whistler

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms